Yüklüyor......
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder (PTSD). If MDMA is FDA-approved it will be important to understand what medications may pose a risk of drug–drug interactions. The goal...
Kaydedildi:
| Yayımlandı: | Sci Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7966744/ https://ncbi.nlm.nih.gov/pubmed/33727616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85389-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|